ASR (688220.SH): plans to issue H-shares and list on HKEX Main Board, board has approved relevant resolutions
NewTimeSpace News: On 15 August 2026, ASR Microelectronics Co., Ltd. (A-share: ASR, 688220) announced in a notice that on 13 August 2026, its third meeting of the third session of the board of directors approved the resolutions on issuing H-shares and listing on the Main Board of The Stock Exchange of Hong Kong Limited, proposing to issue overseas listed foreign shares (H-shares) and apply for a Main Board listing in Hong Kong to further enhance its capital strength and comprehensive competitiveness and advance its internationalization strategy.
According to the announcement, the offering and listing is still subject to review and approval by the Company's shareholders' meeting, and will be carried out subject to compliance with relevant PRC laws, regulations and normative documents and Hong Kong legal requirements, as well as filings, approvals and/or verifications from the CSRC, the Hong Kong Stock Exchange and the SFC and other relevant regulators. As of the date of the announcement, the Company is actively discussing the offering and listing with relevant intermediaries; apart from the resolutions already approved by the board, other specific details of the offering and listing have not yet been finalized.
The announcement notes that whether the offering and listing can pass the review, filing and approval procedures and be ultimately implemented is subject to significant uncertainty, and the Company will fulfill its information disclosure obligations in a timely manner based on subsequent progress.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
- AOM INT'L (00381.HK): Launches Twelve Dynasties Wine Project Combining Cultural Export and Digital Assets
- KINETIC DEV (01277.HK): Sierra Leone Rutile Project Commences Production
- CNE TECH CORP (00611.HK): Acquisition Consideration Adjusted Down to RMB71.93m